YAP1 and non-small cell lung carcinoma: Another study found that the NSCLC cell lines H2030-BrM3 (K-rasG12Cmutation) and PC9-BrM3 (EGFRΔexon19mutation) (derived from the NSCLC cell lines H2030 and PC9 in the laboratory of Professor Joan Massagué, Memorial Sloan Kettering Cancer Center, New York, NY, USA) [99,100], both of which have a high brain metastasis potential, had increased YAP expression levels compared with their parental cell lines (H2030 and PC9).